Lung Cancer Assessment and Early Detection (EarlyCDT)
2007513
Ordering Recommendation
May be useful in screening a select group of individuals 40-75 years who are at high risk for lung cancer (eg, long-term smokers).
Submit With Order
Mnemonic
LUNG ECDT
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Varies
Reported
4-7 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Plain red. Also acceptable: Serum separator tube (SST).  
Specimen Preparation
Transfer 4 mL serum to an ARUP Standard Transport Tube. (Min: 1 mL)  
Storage/Transport Temperature
Room temperature. Also acceptable: Refrigerated or frozen.  
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 1 year  
Reference Interval
Interpretive Data
By report
Note
Testing includes the following autoantibodies: CAGE, GBU4-5, HuD, MAGE A4, NY-ESO-1, p53 and SOX-2.
CPT Code(s)
83520 x7
Components
Component Test Code*Component Chart Name
2007514Lung Cancer Assess/Detect (EarlyCDT)
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
  • Early Lung Cancer Detection
Performed at Oncimmune